A chemo- and radioprotective agent
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

UTL-5g

Item No. 42242

Technical Information
Formal Name
N-(2,4-dichlorophenyl)-5-methyl-3-isoxazolecarboxamide
CAS Number
646530-37-2
Molecular Formula
C11H8Cl2N2O2
Formula Weight
Purity
≥98%
A solid
DMSO: Sparingly soluble: 1-10 mg/mlEthanol: Slightly soluble: 0.1-1 mg/ml
SMILES
O=C(C1=NOC(C)=C1)NC2=CC=C(Cl)C=C2Cl
InChi Code
InChI=1S/C11H8Cl2N2O2/c1-6-4-10(15-17-6)11(16)14-9-3-2-7(12)5-8(9)13/h2-5H,1H3,(H,14,16)
InChi Key
ULPKSWAQDCJLMN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    UTL-5g is a chemo- and radioprotective agent.1,2,3 It reduces LPS-induced transcriptional activity mediated by a variety of immune-related transcription factors, including STAT1, STAT2, STAT3, and SMAD2-4 but not NF-κB in RAW 264.7 macrophages.2 It also reduces hyperphosphorylation of proteins involved in the G2/M phase transition, phagocytosis, and actin remodeling. It reduces radiation-induced increases in liver TNF-α levels in mice when administered at doses of 30 and 60 mg/kg and is protective against liver radiation-induced hepatotoxicity in mice at 60 mg/kg.1 Oral administration of UTL-5g (60 mg/kg) increases the survival rate in a mouse model of acute cisplatin (Item No. 13119) toxicity.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Shaw, J., Zhang, J., Zhang, M., et alPretreatment with a small-molecule tumor necrosis factor-alpha (TNF-α) inhibitor, UTL-5g, reduced radiation-induced acute liver toxicity in mice. Am. J. Biomed. Sci. 4(2), 123-131 (2011).

    2. Carruthers, N.J., Stemmer, P.M., Chen, B., et alPhosphoproteome and transcription factor activity profiling identify actions of the anti-inflammatory agent UTL-5g in LPS stimulated RAW 264.7 cells including disrupting actin remodeling and STAT-3 activation. Eur. J. Pharmacol. 811, 66-73 (2017).

    3. Shaw, J., Media, J., Chen, B., et alThe small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin. Cancer Chemother. Pharmacol. 72(3), 703-707 (2013).